• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [17290 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Radiofrequency denervation for lumbar and cervical facet joint pain – a systematic review
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea. 1st Update 2019
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osteochondral allograft transplantation for the knee (or other joints)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Allograft for anterior and posterior cruciate ligament reconstruction
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Human dermal allograft for massive rotator cuff tears
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) 177Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Custom-made or customisable 3D printed implants and cutting guides versus non- 3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Brentuximab vedotin (Adcetris®) in combination with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCLs)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Irreversible electroporation for the treatment of liver and pancreatic cancer
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening and prevention programmes for children and adolescents from 6 to 14 years. Results from selected countries and recommendations from evidence-based guidelines
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening for Diabetes mellitus: guideline recommendations
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Public & philanthropic financial contribution to the development of new drugs: Methodology & 3 Case Studies
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) FoundationOne®CDx: genetic profiling of solid tumours
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide (Xtandi®) in addition to standard first-line therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Sponsoring of Patient Initiatives in Austria 2018. Update of the Systematic Analyses 2014, 2015 and 2016
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pharma: Disclosure of transfers of value in Austria 2018. Update of the systematic analysis 2015
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) as first-line therapy for PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (NSCLC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening programs for children and adolescents from 6 to 18 years. Results on selected countries, Austrian screening programmes and recommendations from evidence-based guidelines
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rehabilitation for children and adolescents in Austria: A systematic analysis of evaluation methodologies
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cervical Carcinoma Prevention - Implementation of an HPV screening test for early detection of cervical cancer in Austria
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge, state of practice: Use of direct oral anticoagulants and warfarin in the context of atrial fibrillation and venous thromboembolism]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) POCT/ Point of Care Tests: D-Dimer and Troponin
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: anticoagulant therapy]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Minimum volume standards for quality assurance in day surgery: Fundamentals and Systematic Review
2019     Center for Evidence-based Practice (CEP) Pulmonary Artery Catheters Catheter Dwell Time and Routine Replacement
2019     Center for Evidence-based Practice (CEP) Dual Antiplatelet Therapy Following Revascularization for Peripheral Artery Disease
2019     Center for Evidence-based Practice (CEP) Dosing of Botulinum Toxin for Neurologic Indications
2019     Andalusian Health Technology Assessment Area (AETSA) Genetic diseases in Spain. Map of genetic test available in the National Health System. Upgrade.
2019     Center for Evidence-based Practice (CEP) Management of Tunneled Dialysis Catheters in Patients with Bloodstream Infection
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: antidiabetics]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: autonomy in intellectually disabled young people aged 6 to 21 years]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: axicabtagene ciloleucel for the treatment of relapsed or refractory large B-cell lymphoma]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Cutaquig, preparation of human immunoglobulins, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of newborn blood spot screening for biotinidase deficiency (BIOT)]
2019     Center for Drug Evaluation (CDE) Assessment of the benefits of community day-care facilities for the physically and mentally handicapped
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Localized and disseminated stages of Lyme disease: from diagnosis to treatment, report in support of the diagnosis and treatment decision support tools]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: acute exacerbations of chronic obstructive pulmonary disease (AECOPD)]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: urethral discharge]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: effects of assistance dogs and companion animals on persons with autism spectrum disorder or post-traumatic stress disorder]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Esperoct (turoctocog alfa pegol) – Hemophilia A, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: assessing the senior care and services continuum, prospects for measurement development]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated June 2019: palliative care - fever]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards, updated on May 4th 2020 : guide to preventing and treating chemotherapy or radiotherapy-induced nausea and vomiting in adults]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: HemlibraMC (emicizumab) - Hemophilia A, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in July 2019: high blood pressure]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in October 2019: lipid-lowering pharmacologic agents]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: indications justifying the use of imaging for diagnosing patients with primary or secondary headache]
2019     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with influenza vaccination
2019     Adelaide Health Technology Assessment (AHTA) Faecal calprotectin testing in patients suspected of inflammatory bowel disease (IBD) presenting to primary care
2019     Adelaide Health Technology Assessment (AHTA) Immunoglobulin for myasthenia gravis
2019     Adelaide Health Technology Assessment (AHTA) Immunoglobulin for acquired hypogammaglobulinaemia secondary to haematological malignancies, or post-haemopoietic stem cell transplantation (HSCT)
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: managing the risk of suicide and self-harm among youths living in rehabilitation centres for young persons with adjustment problems]
2019     Health Quality Ontario (HQO) Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: withdrawal management in adult addiction rehabilitation service centres]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: the placenta, utility of and indications for the transfer of samples to the anatomical pathology laboratory for analysis]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: post-tick bite antibiotic prophylaxis to prevent Lyme disease, report in support of the knowledge transfer tools, the Québec’s national medical protocol and the collective prescription template]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: mechanisms for accessing local services]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in August 2020: pharmacological treatment of nausea in a person receiving palliative care]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Organization of care and services for stroke to optimize access to endovascular treatment in Quebec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: unusual vaginal discharge]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of low-dose computed tomography lung cancer screening]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: portrait of the Quebec adult trauma care network: 2013 – 2016]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: setting safety and conditions for success of vaginal birth after cesarean]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: intensive outpatient services for youths with psychoactive substance use disorders]
2019     Health Quality Ontario (HQO) Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: dose banding and dose rounding of antineoplastic agents]
2019     Adelaide Health Technology Assessment (AHTA) Heritable Mutations associated with Familial Hypercholesterolaemia
2019     Health Quality Ontario (HQO) Cervical Artificial Disc Replacement Versus Fusion for Cervical Degenerative Disc Disease: A Health Technology Assessment
2019     Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder: an update
2019     Health Technology Wales (HTW) Procalcitonin point-of-care testing for initial assessment of suspected sepsis
2019     Technology Assessment at SickKids (TASK) The economic evaluation of early intervention with anti-tumor necrosis factor-α treatments in pediatric Crohn's disease
2019     Health Technology Wales (HTW) Fluorine- or gallium- prostate-specific membrane antigen (PSMA) positron emission tomography (PET) radiotracers in the investigation of recurrent prostate cancer
2019     Technology Assessment at SickKids (TASK) A cost-utility analysis of biosimilar infliximab compared to reference infliximab in adult switch patients with Crohn’s disease: a Canadian analysis
2019     Health Technology Wales (HTW) Synovasure® Alpha Defensin Lateral Flow Test Kit for the assessment of periprosthetic joint infection
2019     Health Quality Ontario (HQO) Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment
2019     Health Technology Wales (HTW) Hand-held ultrasound devices for cardiac assessment and diagnosis of heart failure, in the community or primary care setting
2019     Health Technology Wales (HTW) Continuous glucose monitoring systems for managing diabetes in pregnant women
2019     Health Quality Ontario (HQO) Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis
2019     Health Technology Wales (HTW) Pharmacogenetic testing to identify the risk of adverse reactions to anti-epileptic medications
2019     Health Quality Ontario (HQO) Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2019     Health Technology Wales (HTW) Robot-assisted thoracic surgery
2019     Ontario Health Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment
2019     Health Technology Wales (HTW) Occipital nerve stimulation for medically refractory chronic cluster headache
2019     Health Sciences Institute in Aragon (IACS) Efficacy, effectiveness and safety of intraoperative radiotherapy in breast carcinoma
2019     Health Sciences Institute in Aragon (IACS) Detection of diabetes' complications. Diabetic retinopathy. Economic evaluation of ultra-wide field scanning laser
2019     Health Technology Wales (HTW) Multi-grip myoelectric upper-limb prosthetics
2019     Ontario Health Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment
2019     Ontario Health Minimally Invasive Glaucoma Surgery: A Budget Impact Analysis and Evaluation of Patients’ Experiences, Preferences, and Values
2019     Belgian Health Care Knowledge Centre (KCE) Polyvalent immunoglobulins – Part 1: A rapid review
2019     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Enzalutamide (prostate cancer) - Addendum to Commission A18-80]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Closed vs open systems for the preparation and administration of cytostatic and other hazardous drugs (NIOSH Group 1): analysis of the scientific evidence, costs and organisational requirements]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Indications, utility and use of ultrasound in primary care]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Controlled and uncontrolled donation after circulatory death with regional normothermic or hypothermic perfusion based on extracorporeal membrane oxygenation for kidney and liver transplants]
2019     Belgian Health Care Knowledge Centre (KCE) Bariatric surgery : an HTA report on the efficacy, safety and cost-effectiveness
2019     Basque Office for Health Technology Assessment (OSTEBA) [Methodological project: Synthesis of information in support of multicriteria decision analysis (MCDA) for decision making]
2019     Belgian Health Care Knowledge Centre (KCE) Cost-effectiveness analysis of HPV vaccination of boys in Belgium
2019     Belgian Health Care Knowledge Centre (KCE) The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: smoking cessation strategies]
2019     Belgian Health Care Knowledge Centre (KCE) Proton beam therapy in adults
2019     Belgian Health Care Knowledge Centre (KCE) Statins for the primary prevention of cardiovascular events